Multi‐Marker Maternal Serum Screening for Chromosomal Abnormalities

This publication has 371 references indexed in Scilit:

• Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith–Lemli–Opitz syndrome (SLOS)
  American Journal of Medical Genetics Part A, 2007
• First‐trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers
  Prenatal Diagnosis, 2005
• Effect of fetal gender on first trimester markers and on Down syndrome screening
  Prenatal Diagnosis, 2001
• First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status
  Prenatal Diagnosis, 2000
• Screening for triploidy by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestation
  Prenatal Diagnosis, 2000
• Screening for trisomy 13 by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestation
  Prenatal Diagnosis, 2000
• Screening for trisomy 21 in twin pregnancies in the first trimester using free ?-hCG and PAPP-A, combined with fetal nuchal translucency thickness
  Prenatal Diagnosis, 2000
• Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free β-hCG levels
  Prenatal Diagnosis, 1999
• Letter. Correct estimation of parameters for ultrasound nuchal translucency screening
  Prenatal Diagnosis, 1998
• Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets
  Prenatal Diagnosis, 1998